Aleafia Health Provides Further Update on its Convertible Debt

TORONTO, June 16, 2022 (GLOBE NEWSWIRE) -- Aleafia Health Inc. (TSX: AH, AH.DB, OTCQX: ALEAF) (“Aleafia Health” or the “Company”) is providing a corporate update regarding its outstanding listed unsecured convertible debentures (TSX:AH-DB.TO), issued on June 27, 2019 and maturing on June 27, 2022 (the “Debentures”). Debentureholders representing approximately 73% of the aggregate principal amount of Debentures outstanding have executed consents and proxies in favour of the amendments to the Debentures (the “Debenture Amendments”) previously announced by the Company on May 12, 2022, exceeding the required 66 2/3% for the written extraordinary resolution to approve the Debenture Amendments. As such, following final tabulation of consents and proxies after 4:00 p.m. (Eastern time) on Friday, June 17, 2022, the Company expects that the extraordinary resolution will be passed by the written consent of the Debentureholders and the meeting scheduled for June 23, 2022 will be cancelled.